Dr. Anmol Naik

Director, Nakshatra Superspecialty Eye Hospital, Pune

4 articles

Dr. Anmol Naik is a Vitreoretinal and cataract surgeon practising in Pune, Maharashtra. He is currently the Director of Nakshatra Superspecialty Eye Hospital, Pune and is a visiting vitreoretinal surgeon and ROP consultant at Ruby Hall Clinic and multiple hospitals across Pune. He completed his masters in Ophthalmology from the prestigious Grant Medical College & Sir J. J. Group of Hospitals, Mumbai with a Silver Medal. Following this, he underwent a rigorous 2-year Surgical vitreoretina fellowship from Sankara Nethralaya, Chennai one of the premier institutes for vitreoretinal diseases in Asia. He holds a meritorious academic record from his school days, having been State ranker in SSC and HSC examinations. He has been the recipient of the Best resident and Best outgoing fellow awards in residency and fellowship respectively. He also has a keen interest in research and has 13 publications in indexed and non-indexed international and national journals to his credit. He has also presented 11 papers in national and international conferences. His areas of interest include diabetic retinopathy, ROP and uveitis.

  1. Articles 1 Apr 2021 14 min read

    Ultrasound B-Scan: A Ready Reckoner for the Postgraduates

    The importance of ultrasound imaging cannot be stressed upon more than the fact that whether you are an anterior segment surgeon, posterior segment surgeon or oculoplastic surgeon, the indications for this modality transcend across all genres of ophthalmology. Many a time, postgraduates find this topic daunting to interpret. This article aims to simplify Ultrasound B-scan in terms of mechanics, terminology, actual procedure, and interpretation without delving deep into the confusing jargon. Some common conditions and their typical presentations will also be touched upon. For ease of understanding, we will divide this article into the following sections: History Basic physics and instrumentation Terminology Indications Examination techniques: basic and special Features of commonly encountered posterior segment conditions History Though the concept of ultrasound waves was known to humans in the 18th century (Lazzaro Spallanzini’s observation on the use of ‘sound whistles’ by bats in dark

    Dr. Anmol Naik · Dr. Shveta Gadewar · +1 other
  2. Articles 1 Apr 2021 4 min read

    Ten Things You Should Know about Brolucizumab

    1. Brolucizumab is a humanized, single-chain variable fragment (scFv) antibody with a molecular mass of approximately 26 kDa that inhibits VEGF-A.[1] (An scFv is an autonomous binding agent that is no longer dependent on a heavy molecular support structure but still retains the full binding capacity to its target). Mechanism of Action of Brolucizumab Unique Properties of Brolucizumab 2. The pharmacokinetics of a single intravitreal (IVT) injection of Brolucizumab in cynomolgus monkeys revealed a mean terminal half-life of 2.4 ± 0.3 days in all ocular compartments. It was cleared from the serum with a mean half-life of 51 hours (approximately 2 days).[2] Brolucizumab Bevacizumab Ranibizumab Aflibercept Molecule Short-chain variable fragment Full antibody (IgG) Monoclonal humanized antibody format Fusion protein Clinical dose in neovascular ARMD 6 mg 1.25 mg* 0.5 mg 2 mg Equivalent Molar dose 11.2-13.3 0.4-0.5 0.5-0.6 1.0 Table: Molecular properties of anti-VEGF agents (ARMD= Age-related

    Dr. Anmol Naik